Establishment of anti-DKK3 peptide for the cancer control in head and neck squamous cell carcinoma (HNSCC)

Naoki Katase(Nagasaki University), Shuichi Fujita(University of Nagasaki)

Cancer Cell International

November 15, 2022

10.1186/s12935-022-02783-9

Cited by 5

Related Papers

Knockdown of Dkk-3 decreases cancer cell migration and invasion independently of the Wnt pathways in oral squamous cell carcinoma-derived cells

|Oncology Reports|2013|27

DKK3 knockdown confers negative effects on the malignant potency of head and neck squamous cell carcinoma cells via the PI3K/Akt and MAPK signaling pathways

|International Journal of Oncology|2018|19

Contemporary clinical characteristics and management patterns in hypertrophic cardiomyopathy: insights from baseline enrolment data in a nationwide prospective Japanese registry

|Heart|2025|3

Differentially Expressed Genes in Head and Neck Squamous Cell Carcinoma: Exploratory Research Using the Cancer Genome Atlas (TCGA) RNA Sequence Data and DESeq2 Package

|Cureus|2025|0